In Vitro Antimicrobial Findings for Fusidic Acid Tested Against Contemporary (2008–2009) Gram-Positive Organisms Collected in the United States

Update on Fusidic Acid (CEM-102) Tested against Neisseria gonorrhoeae and Chlamydia trachomatis

(2010) R. N. Jones et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008

(2010) M. Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102)

(2010) Douglas J. Biedenbach et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Staphylococcus aureus elongation factor G - structure and analysis of a target for fusidic acid

(2010) Yang Chen et al.   FEBS Journal

Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)

(2010) M. Castanheira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Performance of Fusidic Acid (CEM-102) Susceptibility Testing Reagents: Broth Microdilution, Disk Diffusion, and Etest Methods as Applied toStaphylococcus aureus

(2010) Ronald N. Jones et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus

(2009) J. Lannergard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada

(2009) Michael A. Pfaller et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-Tu

(2009) Xabier Agirrezabala et al.   QUARTERLY REVIEWS OF BIOPHYSICS

The Structure of the Ribosome with Elongation Factor G Trapped in the Posttranslocational State

(2009) Y.-G. Gao et al.   SCIENCE

First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

(2008) R. E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France

(2008) F. Laurent et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections

(2008) A. R. Larsen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis

(2008) F. McLaws et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY